Acute Myeloid Leukemia
📧 Sign up to get email alerts when something new happens for Acute Myeloid Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2014-01-08Clinical Trial Update: T-cell Depleted Donor Lymphocyte Infusion (DLI)for Acute Myeloid Leukemia (AML) or High Risk Myelodysplastic Syndrome (MDS) [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating T-cell depleted donor lymphocyte infusion for acute myeloid leukemia and high-risk myelodysplastic syndr…
-
CLINICAL_TRIALS trial_result · 2014-01-06Clinical Trial Update: Tipifarnib in Treating Older Patients With Acute Myeloid Leukemia [Phase 2]
A Phase 2 trial of tipifarnib in older adults with acute myeloid leukemia has completed, with results posted in January 2014.
-
CLINICAL_TRIALS trial_result · 2014-01-06Clinical Trial Update: Oblimersen and Gemtuzumab Ozogamicin in Treating Older Patients With Relapsed Acute Myeloid Leukemia [Phase 2]
Phase 2 trial results evaluating the combination of oblimersen and gemtuzumab ozogamicin in older patients with relapsed acute myeloid leuke…
-
CLINICAL_TRIALS trial_result · 2014-01-06Clinical Trial Update: Azacitidine and Gemtuzumab Ozogamicin in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia [Phase 2]
Phase 2 trial update on the combination of azacitidine and gemtuzumab ozogamicin in older patients with previously untreated acute myeloid l…
-
CLINICAL_TRIALS research · 2014-01-06Clinical Trial Update: Vaccine Therapy and GM-CSF in Treating Patients With Acute Myeloid Leukemia in Remission [Phase 3]
Phase 3 trial evaluating vaccine therapy in combination with GM-CSF for patients with acute myeloid leukemia in remission is underway. The c…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2014-01-03Clinical Trial Update: ALT-801-activated Natural Killer Cells After FLAG Induction for Acute Myeloid Leukemia [Phase 1]
The clinical trial evaluating ALT-801-activated natural killer cells with FLAG induction for acute myeloid leukemia (NCT01478074) has been w…
-
CLINICAL_TRIALS trial_result · 2014-01-01Clinical Trial Update: A Pediatric Study of a Plerixafor Containing Regimen In Second Allogeneic Stem Cell Transplantation [Phase 1]
A Phase 1 pediatric study evaluating a plerixafor-containing regimen as part of a second allogeneic stem cell transplantation has completed.
-
CLINICAL_TRIALS trial_result · 2013-12-31Clinical Trial Update: AML1-ETO Acute Myeloid Leukemia With Fludarabine and Cytarabine Chemotherapy [Phase 4]
A Phase 4 clinical trial update evaluating fludarabine and cytarabine chemotherapy for Acute Myeloid Leukemia with AML1-ETO fusion expressio…
-
CLINICAL_TRIALS trial_result · 2013-12-23Clinical Trial Update: A Randomized Trial of Procrit vs. No Procrit in AML and High Risk MDS [Phase 3]
A Phase 3 randomized trial comparing Procrit (epoetin alfa) versus no Procrit in patients with acute myeloid leukemia and high-risk myelodys…
-
CLINICAL_TRIALS trial_result · 2013-12-20Clinical Trial Update: Timed-Sequential Induction in CBF-AML [Phase 3]
A Phase 3 clinical trial evaluating timed-sequential induction in core-binding factor acute myeloid leukemia has completed.
-
CLINICAL_TRIALS trial_result · 2013-12-20Clinical Trial Update: Lestaurtinib, Cytarabine, and Idarubicin in Treating Younger Patients With Relapsed or Refractory Acute Myeloid Leukemia [Phase 1, Phase 2]
Clinical trial update reporting Phase 1/Phase 2 results for a Lestaurtinib–Cytarabine–Idarubicin regimen in younger patients with relapsed o…
-
CLINICAL_TRIALS trial_result · 2013-12-19Clinical Trial Update: Combination Chemotherapy With or Without Filgrastim and/or Tretinoin in Treating Patients With Acute Myeloid Leukemia [Phase 3]
A Phase 3 trial evaluating whether adding filgrastim and/or tretinoin to standard chemotherapy improves outcomes in patients with acute myel…
-
CLINICAL_TRIALS research · 2013-12-19Clinical Trial Update: Combination Chemotherapy, Biological Therapy, and Bone Marrow Transplantation in Treating Patients With Acute Myeloid Leukemia [Phase 3]
A Phase 3 clinical trial is evaluating the combination of chemotherapy, biological therapy, and bone marrow transplantation for treating acu…
-
CLINICAL_TRIALS trial_result · 2013-12-19Clinical Trial Update: Monoclonal Antibody in Treating Patients With Acute Myelogenous Leukemia [Phase 2]
Phase 2 clinical trial update evaluating a monoclonal antibody for treating acute myeloid leukemia.
-
CLINICAL_TRIALS research · 2013-12-19Clinical Trial Update: Cyclosporine and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia [Phase 2]
Clinical trial update for a Phase 2 study of cyclosporine with combination chemotherapy in relapsed or refractory acute myeloid leukemia; cu…
-
CLINICAL_TRIALS trial_result · 2013-12-18Clinical Trial Update: Intensive Compared With Nonintensive Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome [Phase 3]
Phase 3 trial comparing intensive versus nonintensive chemotherapy in older adults with acute myeloid leukemia or myelodysplastic syndromes.…
-
CLINICAL_TRIALS trial_result · 2013-12-18Clinical Trial Update: Combination of 5-azacitidine and Lenalidomide in Myelodysplastic Syndromes (MDS) or Acute Myelogenous Leukemia (AML) Myelodysplastic Syndromes [Phase 1]
A Phase 1 trial evaluating the combination of 5-azacitidine and lenalidomide in myelodysplastic syndromes and acute myeloid leukemia was ter…
-
CLINICAL_TRIALS trial_result · 2013-12-16Clinical Trial Update: Intermittent Liposomal Amphotericin B Primary Prophylaxis [Phase 2]
An update on a Phase 2 trial evaluating intermittent liposomal amphotericin B as primary prophylaxis for fungal infections in Acute Myeloid …
-
CLINICAL_TRIALS research · 2013-12-11Clinical Trial Update: Phase I/II Trial: BIBF 1120 Added to Low-dose Cytarabine in Elderly Patients With Acute Myeloid Leukemia (AML) [Phase 1, Phase 2]
Phase I/II clinical trial testing BIBF 1120 (nintedanib) added to low-dose cytarabine in elderly patients with Acute Myeloid Leukemia.
-
CLINICAL_TRIALS trial_result · 2013-12-10Clinical Trial Update: A Phase I Study of WT1 Peptides to Induce Anti-Leukemia Immune Responses Following Transplantation [Phase 1]
A Phase I study evaluating WT1 peptide immunotherapy to induce anti-leukemia immune responses after transplantation was terminated.
-
CLINICAL_TRIALS trial_result · 2013-12-05Clinical Trial Update: MLN4924 for the Treatment of Acute Myelogenous Leukemia, Myelodysplastic Syndrome, and Acute Lymphoblastic Leukemia [Phase 1]
Phase 1 clinical trial update showing results for MLN4924 (pevonedistat) in acute myeloid leukemia, acute lymphoblastic leukemia, and myelod…
-
CLINICAL_TRIALS trial_result · 2013-12-05Clinical Trial Update: Alvocidib, Cytarabine, and Mitoxantrone in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia [Phase 2]
Phase 2 trial evaluating alvocidib, cytarabine, and mitoxantrone in adults with newly diagnosed acute myeloid leukemia shows results were po…
-
CLINICAL_TRIALS trial_result · 2013-12-04Clinical Trial Update: Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Children With Acute Myeloid Leukemia [Phase 3]
A Phase 3 trial comparing combination chemotherapy with or without bone marrow transplantation in children with acute myeloid leukemia. The …
-
CLINICAL_TRIALS trial_result · 2013-12-03Clinical Trial Update: Fludarabine and Cytarabine in Acute Myelogenous Leukemia (AML) and High-Risk Myelodysplastic Syndrome (MDS) [Phase 2]
Phase 2 trial results evaluate the combination of fludarabine and cytarabine in patients with acute myeloid leukemia and high-risk myelodysp…
-
CLINICAL_TRIALS trial_result · 2013-11-27Clinical Trial Update: Intraosseous Infusion of Unrelated Cord Blood Grafts [NA]
Clinical trial evaluating intraosseous infusion of unrelated cord blood grafts was terminated; sponsor was Emory University, and it studied …